Clinical Trial Update: Effect of Tranexamic Acid (TXA) on Reduction of Postoperative Blood Transfusion [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether tranexamic acid reduces postoperative blood transfusion in hip fracture surgery; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hip Fracture

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Gregory M Georgiadis MD | Conditions: Hip Fractures | Phase 4 | Status: RECRUITING